Cargando…
Warp-Speed Covid-19 Vaccine Development: Beneficiaries of Maturation in Biopharmaceutical Technologies and Public-Private Partnerships
It is anticipated that effective vaccines will enable the resumption of social and economic normalcy. Current calls for masking, social distancing and other restrictive measures for the public-good are difficult to enforce and are unstainable. As ~2–4% of the 50 million SARS-CoV2-infected have succu...
Autor principal: | Ho, Rodney J.Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Pharmacists Association®. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671640/ https://www.ncbi.nlm.nih.gov/pubmed/33212162 http://dx.doi.org/10.1016/j.xphs.2020.11.010 |
Ejemplares similares
-
Innovative public–private partnership to target subsidised antimalarials: a study protocol for a cluster randomised controlled trial to evaluate a community intervention in Western Kenya
por: Laktabai, Jeremiah, et al.
Publicado: (2017) -
Is It Time for Operation Warp Speed in Transplant Research?
por: Mannon, Roslyn B.
Publicado: (2020) -
Leveraging technology in public-private partnerships: a model to address public health inequities
por: Arnaout, Angel, et al.
Publicado: (2023) -
Public – private 'partnerships' in health – a global call to action
por: Nishtar, Sania
Publicado: (2004) -
Public private partnership in vascular surgery
por: Mendes, Cynthia de Almeida, et al.
Publicado: (2014)